It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
There is a relative scarcity of large-scale population studies investigating the relationship between the insulin resistance index of homeostasis model assessment (HOMA-IR) and vascular damage. Therefore, we assessed the association between HOMA-IR and vascular damage in adults aged 18 years and older in China. A total of 17,985 research subjects were included. Vascular damage markers and relevant laboratory tests were measured. HOMA-IR was calculated as (fasting insulin * fasting blood glucose)/22.5. Vascular damage included arteriosclerosis (ba-PWV > 1800 cm/s), peripheral artery disease (ABI < 0.9), and microalbuminuria (UACR > 30 mg/g). The relationship between HOMA-IR and vascular damage was analyzed using the RCS. The restricted cubic spline (RCS) analysis suggested that HOMA-IR was nonlinearly associated with arteriosclerosis (P for no-liner < 0.01), peripheral artery disease (P for no-liner < 0.01), and microalbuminuria (P for no-liner < 0.01). Further segmented regression analyses revealed that in study subjects with HOMA-IR < 5, we found that HOMA-IR was associated with an increased OR for arteriosclerosis (OR: 1.36, 95% CI (1.28, 1.45), P < 0.01), peripheral artery disease (OR: 1.33, 95% CI (1.10, 1.60), P < 0.01) and microalbuminuria (OR: 1.59, 95% CI (1.49, 1.70), P < 0.01). HOMA-IR is an independent risk factor for vascular damage, both macrovascular and microvascular. The phenomenon of saturation of HOMA-IR with vascular damage needs further investigation.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Chinese PLA General Hospital and Medical School of Chinese PLA, Beijing, China (GRID:grid.414252.4) (ISNI:0000 0004 1761 8894); The Second Medical Center and National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing, China (GRID:grid.414252.4) (ISNI:0000 0004 1761 8894); The Second Medical Center and National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Department of Health Management, Beijing, China (GRID:grid.414252.4) (ISNI:0000 0004 1761 8894)
2 Chinese PLA General Hospital and Medical School of Chinese PLA, Beijing, China (GRID:grid.414252.4) (ISNI:0000 0004 1761 8894); The Second Medical Center and National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing, China (GRID:grid.414252.4) (ISNI:0000 0004 1761 8894); The Second Medical Center and National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Department of Nephrology, Beijing, China (GRID:grid.414252.4) (ISNI:0000 0004 1761 8894)
3 Chinese PLA General Hospital and Medical School of Chinese PLA, Beijing, China (GRID:grid.414252.4) (ISNI:0000 0004 1761 8894); The Second Medical Center and National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Department of Geriatrics, Beijing, China (GRID:grid.414252.4) (ISNI:0000 0004 1761 8894); The Second Medical Center and National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing, China (GRID:grid.414252.4) (ISNI:0000 0004 1761 8894)